A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

This trial tests an experimental drug called AZD6750 in people with advanced or metastatic solid tumors that have not responded to standard treatments. The drug is designed to help the immune system fight cancer more effectively. **You may be eligible if...** - You are 18 or older and weigh at least 35 kg (77 lbs) - You have confirmed advanced cancer (eligible types include skin cancers, lung cancer, head and neck cancer, gastric cancer, kidney cancer, ovarian cancer, or triple-negative breast cancer) - You have received standard-of-care treatment already - Your heart, liver, bone marrow, and kidneys are functioning adequately **You may NOT be eligible if...** - You have a history of organ or stem cell transplant - You have an active or recent autoimmune or inflammatory disorder - You have severe or uncontrolled heart, lung, or other systemic disease - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.